Alsagban Alhareth, Saab Omar, Al-Obaidi Hasan, Algodi Marwah, Yu Amy, Abuelazm Mohamed, Hochberg Chad
Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.
Department of Medicine, University of Texas at Houston, Houston, TX 77082, USA.
Med Sci (Basel). 2025 Jun 14;13(2):78. doi: 10.3390/medsci13020078.
Establishing prompt vascular access facilitates resuscitation for out-of-hospital cardiac arrest (OHCA). While intraosseous access may decrease the time to vascular access, the impact on clinical outcomes in OHCA is unclear. Therefore, we aim to compare the effect of intraosseous (IO) versus intravenous (IV) vascular access on clinical outcomes after OHCA resuscitation. A systematic review and meta-analysis were performed to synthesize evidence from randomized controlled trials (RCTs) obtained from PubMed, CENTRAL, Scopus, and Web of Science until January 2025. Using Stata MP v. 17, we used the fixed-effects model to report dichotomous outcomes using the risk ratio (RR) and continuous outcomes using the mean difference (MD) with a 95% confidence interval (CI). PROSPERO ID: CRD42024627354. Four RCTs and 9475 patients were included. There was no difference between both groups regarding the prehospital return of spontaneous circulation (ROSC) (RR: 0.97, 95% CI [0.91, 1.03], = 0.33), maintained ROSC (RR: 0.94, 95% CI [0.87, 1.01], = 0.09), survival to discharge (RR: 1.03 with 95% CI [0.88, 1.21], = 0.71), 30-day survival (RR: 0.98, 95% CI [0.82, 1.17], = 0.79), or favorable neurological recovery (RR: 1.07, 95% CI [0.90, 1.29], = 0.44). However, IO access significantly increased first-attempt access (RR: 1.24, 95% CI [1.19, 1.29], < 0.001), decreased time to vascular access (MD: -0.24 min with 95% CI [-0.48, -0.01], = 0.04), and decreased time to drug administration (MD: -0.38, 95% CI [-0.66, -0.10], = 0.01). IO and IV vascular accesses showed similar clinical outcomes in OHCA patients, with no difference in ROSC, survival, or neurological recovery. Still, IO access showed a better procedural outcome with increased first-attempt success rates, faster access, and faster drug administration.
建立快速的血管通路有助于院外心脏骤停(OHCA)的复苏。虽然骨内通路可能会减少建立血管通路的时间,但对OHCA临床结局的影响尚不清楚。因此,我们旨在比较骨内(IO)与静脉(IV)血管通路对OHCA复苏后临床结局的影响。进行了一项系统评价和荟萃分析,以综合从PubMed、CENTRAL、Scopus和Web of Science获取的截至2025年1月的随机对照试验(RCT)证据。使用Stata MP v. 17,我们使用固定效应模型报告二分结局的风险比(RR)和连续结局的平均差(MD),并给出95%置信区间(CI)。PROSPERO注册号:CRD42024627354。纳入了4项RCT和9475例患者。两组在院外自主循环恢复(ROSC)(RR:0.97,95%CI[0.91,1.03],P = 0.33)、维持ROSC(RR:0.94,95%CI[0.87,1.01],P = 0.09)、出院存活(RR:1.03,95%CI[0.88,1.21],P = 0.71)、30天存活(RR:0.98,95%CI[0.82,1.17],P = 0.79)或良好神经功能恢复(RR:- 1.07,95%CI[0.90,1.29],P = 0.44)方面无差异。然而,骨内通路显著提高了首次尝试通路成功率(RR:1.24,95%CI[1.19,1.29],P < 0.001),缩短了建立血管通路的时间(MD:-0.24分钟,95%CI[-0.48,-0.01],P = 0.04),并缩短了给药时间(MD:-0.38,95%CI[-0.66,-0.10],P = 0.01)。在OHCA患者中,骨内和静脉血管通路显示出相似的临床结局,在ROSC、存活或神经功能恢复方面无差异。不过,骨内通路在操作结局方面表现更好,首次尝试成功率更高、通路建立更快且给药更快。